nference
PrivateLast Round
Accelerator
Dec 1, 2022
Total Funding Raised
$134.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
nference is a health technology company that develops an AI-driven software platform to convert unstructured data from electronic medical records into actionable insights for pharmaceutical, biotechnology, and healthcare organizations.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Drug Discovery, Clinical Trials, Medical AI, EHR & EMR
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
nference Comparables
Compare nference with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TriNetX | 88% | |
| Truveta | 87% | |
| Verana Health | 86% | |
nference Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 1, 2022 | ||||
| Series C | Dec 15, 2020 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Jun 6, 2018 | ||||
| Seed | Jan 10, 2016 |
Key People
Founding team and executive leadership
nference Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Seed, Series B, Series A, Series C |
| Mayo Clinic Ventures | Series C |
| Matrix Capital Management | Series A, Series B, Series C |
| NTTVC | Series C, Series B |
| Mayo Clinic Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 48% MoM, reaching 7.1K.
- Mar 10, 2026
Collaborating with Mayo Clinic for medical insights.
nference Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about nference's valuation, stock price, and market status.